The effect of benralizumab on inflammation in severe asthma: a real-life analysis
Background: Benralizumab is a monoclonal antibody treatment for severe eosinophilic asthma (SEA). Few studies investigated its role in airway inflammation and its correlation with lung function. Objectives: The aim of the present study is to assess its effect after 1 year of treatment, focusing on a...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publishing
2024-12-01
|
| 叢編: | Therapeutic Advances in Respiratory Disease |
| 在線閱讀: | https://doi.org/10.1177/17534666241304685 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|